World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 15 July 2019
Main ID:  ACTRN12618000291280
Date of registration: 26/02/2018
Prospective Registration: Yes
Primary sponsor: Universiti Putra Malaysia
Public title: Effectiveness of quit smoking motivation with carbon monoxide feedback module (COQUIT) among college smoker in Selangor
Scientific title: Effectiveness of quit smoking motivation with carbon monoxide feedback module (COQUIT) among college smoker in Selangor
Date of first enrolment: 16/04/2018
Target sample size: 160
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12618000291280.aspx
Study type:  Interventional
Study design:  Purpose: Educational / counselling / training; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;  
Phase:  Not Applicable
Countries of recruitment
Malaysia
Contacts
Name: Dr muhammad adil zainal abidin   
Address:  Department of Community Health, Faculty of Medicines and Health Sciences, Universiti Putra Malaysia, Serdang, 43400,Selangor, Malaysia. Malaysia
Telephone: +60142102021
Email: adilzainal@gmail.com
Affiliation: 
Name: Dr muhammad adil zainal abidin   
Address:  Department of Community Health, Faculty of Medicines and Health Sciences, Universiti Putra Malaysia, Serdang, 43400,Selangor, Malaysia. Malaysia
Telephone: +60142102021
Email: adilzainal@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: i) Students at Community College in Selangor, Malaysia.
ii) Age between 18 to 24 years old.
iii) Currently smokes either every day or some days.
iv) Smokers at the stage of pre-contemplation and contemplation phase.
v) Understand English.

Exclusion criteria: i) Smokers at the stage of preparation, action or maintenances phase.
ii) Smokers currently on smoking cessation program or self-quit attempt.
iii) Smokers with lung or heart diseases as reported.


Age minimum: 18 Years
Age maximum: 24 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Public Health - Epidemiology
nicotine addiction;
nicotine addiction
Mental Health - Addiction
Intervention(s)
The feedback mechanism consists of expired carbon monoxide measurement result using mobile phone application. The iCO Smokelyzer (Bedfront Scientific Ltd., Rochester, UK) will be used to measure the carbon monoxide level. First, the participant carbon monoxide level will be measured on one to one basis. The CO reading will be record directly into the iPad together with explained feedback about the result interpretation. For each test, a disposable cardboard and alcohol-free wipes will be used to clean the device for disinfection procedure. The result of the CO will be emailed to the participants. The measurement of the expired carbon monoxide will be done by the principal investigator. The feedback of the measurement to the smokers to increase their motivation for intention to quit smoking.

. The brief advice consists of motivational intervention based on “5 R’s”; relevance, risks, rewards, roadblocks, and repetition. This 5R’s was based on the National Clinical Practice Guidelines as described below. The brief motivation will be delivered by the trained counsellor on a one to one basis. The 5R motivational intervention will consist of 10 minutes of intervention based on the module from Ministry of Health (MOH) manual for quit smoking clinic. The 5R theme are as below:

Relevance
• Encourage the patient to indicate why quitting is personally relevant, being as specific as possible. Motivational information has the greatest impact if it is relevant to a patient’s disease status or risk, family or social situation (e.g. having children in home)


Risks
• The staff will as the patient to identify potential negative consequences of tobacco use. The staff may suggest and highlight those that seem most relevant to the patient. The staff will emphasize that switching to low-tar/low nicotine cigarette or other forms of tobacco will still have similar risks. Example of risks are:
Short-term risks: Shortness of breath, exacerbation of asthma,
Primary Outcome(s)
The primary outcome measure are stage of changes based on the Transtheoretical Model that will be measure using validated questionnaire. Each participant will be contacted during each follow up timepoint. The questionnaire has been translated and validated in Malay language.
Yasin, S. M., Taib, K. M., & Zaki, R. A. (2011). Reliability and construct validity of the Bahasa Malaysia version of transtheoretical model (TTM) questionnaire for smoking cessation and relapse among Malaysian adult. Asian Pacific J Cancer Prev, 12, 1439-1443.[The primary timepoints is at 1 month post intervention follow by 3 month and 6 month post intervention.]
Secondary Outcome(s)
The secondary outcome measured are smoking characteristics consist of any quit attempt define as 24 hour not smoking. The outcome will be measured using questionnaire. All participants will be contacted during each follow up time point. The questionnaire will be specifically develop for this study.[1 month , 3 month and 6 month post intervention.]
The other secondary outcome measured are smoking characteristics consist of number of cigarette smoker per day and smoking habit. The outcome will be measured using questionnaire. All participants will be contacted during each follow up time point. The questionnaire will be specifically develop for this study.[1 month, 3 month and 6 month post intervention.]
Secondary ID(s)
None
Source(s) of Monetary Support
Universiti Putra Malaysia (UPM)
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
ETHIC COMMITTEE FOR RESEARCH INVOLVING HUMAN SUBJECT
Results
Results available: Yes
Date Posted: 28/03/2019
Date Completed: 12/11/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history